In 2023, the trade exchange (includes international purchases and sales) of Appliances which are Worn own Person or Implanted to Compensate for a Defect or Disability (Exc. Articles and Prosthetic Devices, as well as Headsets and Cardiac Stimulator, Complete) was US$367M.
In 2023, the states with the most international sales in Appliances which are Worn own Person or Implanted to Compensate for a Defect or Disability (Exc. Articles and Prosthetic Devices, as well as Headsets and Cardiac Stimulator, Complete) were Baja California (US$198M), Chihuahua (US$12.4M), Tamaulipas (US$7.21M), and Ciudad de México (US$1.84M).
The states with the most international purchases in 2023 were Baja California (US$65.9M), Ciudad de México (US$39.6M), Jalisco (US$9.81M), Nuevo León (US$8.63M), and Chihuahua (US$7.14M).
In 2023, the main commercial destinations of Appliances which are Worn own Person or Implanted to Compensate for a Defect or Disability (Exc. Articles and Prosthetic Devices, as well as Headsets and Cardiac Stimulator, Complete) were United States (US$212M), Canada (US$3.29M), Poland (US$2.06M), Austria (US$1.43M), and China (US$374k).
The main commercial origins of Appliances which are Worn own Person or Implanted to Compensate for a Defect or Disability (Exc. Articles and Prosthetic Devices, as well as Headsets and Cardiac Stimulator, Complete) in 2023 were United States (US$33.9M), Singapore (US$18.2M), Philippines (US$17.5M), Denmark (US$10.5M), and Germany (US$10.1M).
In the global context, the main exporting countries of Appliances which are Worn own Person or Implanted to Compensate for a Defect or Disability (Exc. Articles and Prosthetic Devices, as well as Headsets and Cardiac Stimulator, Complete) in 2022 were United States (US$3.25B), Ireland (US$1.82B), and Netherlands (US$1.5B). In the same year, the main importing countries of Appliances which are Worn own Person or Implanted to Compensate for a Defect or Disability (Exc. Articles and Prosthetic Devices, as well as Headsets and Cardiac Stimulator, Complete) were United States (US$1.98B), Netherlands (US$1.79B), and Germany (US$1.64B).